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 Swietenia macrophylla King, a plant used extensively in many countries for medicinal 
purposes. The objective of the present study was to investigate in vitro antifungal 
activity of the extract as well as bioassay-guided isolation and identification of 
compounds from most active fraction of S. macrophylla seeds. In the antifungal assay, 
three clinical fungal strains; namely, Aspergillus flavus, Candida albicans and 
Aspergillus niger were tested by disc diffusion method. Solvent partitioning followed 
by Preparative High Performance Liquid Chromatography (prep-HPLC) of the most 
active fraction afforded four known limonoids and identified by spectroscopic 
techniques including Fourier Transform Infrared Spectroscopy (FTIR), Mass 
Spectrometry (MS) and Nuclear Magnetic Resonance Spectroscopy (NMR) analyses.  
The compounds were: swietenolide (1), proceranolide (2), 3-O-tigloyl-6-O-
acetylswietenolide (3) and swietenine acetate (4). Among the fractions, ethyl acetate 
was the most dominant and effective fraction. Moreover, three compounds (1-3) 
showed moderate to weak activity, whereas all tested organisms completely resistant to 
compound 4 and no inhibition zone was observed. On overall, among the three active 
compounds; compound 1 showed more potent activity than other compounds against all 
tested organisms.  
 
INTRODUCTION 
 
Switenia macrophylla king is a genus of three species of plants in the family Meliaceae, which is natively 
distributed throughout tropical regions of the Americas, mainly in Brazil, Bolivia, Mexico and Central America 
(Eid et al., 2013; Li-Chai et al., 2015). S. macrophylla is a lofty, beautiful, evergreen shrub and large tree which 
grows to a height of 30-40 m and girth of 3-4 m, depending on the variety (Moghadamtousi et al., 2013). It has 
been included in traditional medicinal formulations for the treatment of diabetes, hypertension and to relieve 
pain (Dutta et al., 2013). The extracts of S. macrophylla showed different biological activities such as, 
antimicrobial, anti-inflammatory, antioxidant, anti-mutagenic, anticancer, antitumor and antidiabetic activities 
(Goh and Kadir, 2011). Limonoids and their derivatives isolated from S. macrophylla exhibited effective anti-
inflammatory (Chen et al., 2010; Li-Chai et al., 2015) and antibacterial activities (Shahidur Rahman et al., 
2009). 
Infectious diseases caused by fungal represent a critical problem to health and they are one of the main 
causes of morbidity and mortality worldwide (Rahul et al., 2012). Candida and Aspergillus species are 
responsible for the majority (80 to 90%) of fungal infections (Espinel-Ingroff et al., 2005). Candida albicans is 
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the third- or fourth-most-common isolate in nosocomial bloodstream infections in the USA. It is mainly 
responsible of gastrointestinal tract and candidiasis infections (Eggimann et al., 2003; Zadik et al., 2010). 
Aspergillus niger is a ubiquitous filamentous fungus found in grains, fruits, forage, mouldy vegetables and dairy 
products. A. niger is a toxinogenic specie that can produce ochratoxin A (Latifa et al., 2012). It is also a 
pathogenic mold that causes otomycosis and aspergillosis (Araiza et al., 2006; Bulpa et al., 2007). In spite of the 
introduction of new antifungal drugs, they are limited in number. The increase of fungal resistance to classical 
drugs and the treatment costs, justify the search for new antifungal drugs from different sources. However, the 
synthesis of a new drug is too expensive, wasting products in the process; the drugs unstable and may be 
creating toxic as by products. Furthermore, the environmental problems associated with synthetic of new drugs 
have to be considered. Plants are rich sources for a wide variety of phytochemicals. The presence of these 
phytochemicals in plants makes it to be a possible source of raw materials for many pharmaceutical industries as 
therapeutics sources. By this safer way and cheaper in price, natural drug can be originated. Nevertheless, 
several medicinal plants for different reasons have not received sufficient scientific studies and sometimes are 
classified as ‘forgotten plants’. The growing interest in medicinal plants or herbs as a source of new 
pharmaceuticals and the increasing demand for herbal products in the world encourage us to revise this plant 
(Swietenia macrophylla) by evaluating its applicability and benefits using advanced scientific approaches to 
increase our information about its biological effects and the responsible phytochemicals from them. Thus, this 
study aimed to isolate and identify bioactive compounds (limonoids) from S. macrophylla seed, that might act as 
antifungal agents and to determine their antifungal potential against Aspergillus flavus, Candida albicans and 
Aspergillus niger, through a guided antifungal bioassay (Bioassay-guided isolation and identification). 
 
MATERIALS AND METHODS 
 
General: 
The proton nuclear magnetic resonance (1H NMR, 500 MHz) and carbon nuclear magnetic resonance (13C 
NMR, 125 MHz) spectra in CD3OD were performed on a Bruker NMR Spectrometer (Bruker Corp., Germany) 
with TMS as an internal standard. IR was achieved on a Perkin Elmer 100 FT-IR Spectrophotometer (Perkin 
Elmer, Inc., USA) system. The mass spectra were conducted using Agilent 1290 Infinity LC system (Waters 
Corp., USA) coupled to Agilent 6520 Accurate-Mass Q-TOF mass spectrometer (Agilent Tech., USA) with dual 
ESI source. The column used was Agilent Zorbax Eclipse Plus C18, Rapid Resolution HD (2.1 x 50mm, 1.8um) 
Part no: 959757-902. HPLC carried out on Waters HT XDB- C18 column using 30-70% H2O/ACN as solvent. 
 
Plant Materials: 
Seed of S. macrophylla King were collected on 16 December, 2010 from Bukit Mertajam, Penang, 
Malaysia. The taxonomy and identification of the plant was done by the botanist in the School of Environment 
Science and Natural Resources, University of Malaya (UM). 
 
Extraction and Isolation: 
Dried and ground seed of S. macrophylla (900 g) were macerated in methanol for five days at room 
temperature with occasional shaking and stirring. The result extract was filtered through a sieve and finally with 
Whatman no. 1 filter papers. The volume of filtrate was concentrated using a rotary evaporator to obtain the 
crude extract (63.5 g). A portion of the crude extract (20 g) was re-dissolved in 5% methanol solution (200 mL), 
fractionated successfully with hexane, chloroform and ethyl acetate to give hexane (3.8 g), chloroform (5.7 g), 
ethyl acetate (4.4 g) and aqueous (4.5 g) fractions. The isolation was performed on the seed ethyl acetate 
fraction, which was the most active antimicrobial fraction. The ethyl acetate fraction (4.4 g) was purified 
through column chromatography packed with silica gel (70-230 mesh), and elution was conducted in an 
increasing polarity solvent system using (mobile phase: dichloromethane and methanol of increasing polarity), 
yielding two major fractions. The combination of these two fractions yielded 2.8 g. About, 500 mg of this 
sample was dissolved in 50 mL methanol (HPLC grade) and filtered through a 0.2 mm membrane filter. The 
final solution was used for analytical and preparative HPLC analysis. 
The sample solution was screened for the presence of compounds via analytical method before conducting 
the preparative HPLC. In the analytical method, the separation was achieved on a prep-HPLC 25455 Binary 
Gradient Model System with analytical column C18-Zorbax Eclipse XDB (4.6 x 150 mm i.d; particle size 5 µm) 
by using two chromatographic pumps. The elution was performed by gradient solvent systems with a flow rate 
of 1 mL/min at ambient temperature (25-28 °C). The mobile phase consisted of 70% water (solvent A) and 30% 
acetonitrile (solvent B) changed gradually to 90% acetonitrile within 15 minutes and held for another five 
minutes. The mobile phase was prepared freshly, filtered through a 0.2 mm membrane filter and degassed via 
sonication before use. Total running time was 20 mins. The sample injection volume was 10 µL of the solution, 
while the wavelength of the UV-Vis detector was set at 230 nm. In the preparative method, the sample was 
injected into the same instrument and further separation and collection of the targeted compounds were done 
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through the preparative column of C18-Zorbax Eclipse XDB (21.2 x 150 mm i.d; particle size 7 µm) and 
fractions collector. The solvent system was the same as the analytical analysis. The injection volume was 
increased to 210 µL at flow rate of 19 mL/min. 
 
Antifungal Susceptibility Test: 
All fractions and isolated compounds were screened against three funguses namely: A. flavus (MTCC 
1973), C. albicans (MTCC 183) and A. niger (MTCC 16404) by the conventional disc diffusion method (Majid 
et al., 2004). Stock solutions 10 mg/mL were prepared from the 100 mg of each fraction in 10 mL of solvent 
(9.5 mL H2O + 0.5 mL DMSO), and sterilized discs were impregnated with 5 and 10 mg/mL of each fraction, 
and dried. Standard discs of Fluconazole (10 µg/disc) and 5% DMSO were used as the positive and negative 
controls, respectively. Each sample and control discs were carefully placed onto the previously marked zones on 
the agar plates pre-inoculated with test organisms. The plates were incubated at 37 °C for five days in upright 
positions. After incubation, the antifungal effect of tested materials was determined by measuring the diameter 
of the inhibition zones in mm with a transparent scale. Figure 1 shows the flow chart process for the bioassay-
guided isolation and identification of limonoids from S. macrophylla King 
 
Statistical Analysis: 
The results obtained in the current work were analysed using SPSS software (SPSS Statistical Version 22). 
All values presented are mean values ± standard deviation of triplicates (n = 3), obtained from three separate 
experiments. The one-way ANOVA and post hoc multiple comparisons test (Scheffe) were performed to 
examine the differences among the groups. A P value of < 0.05 was considered to be statistically significant. 
 
 
Fig. 1: Flow chart for the bioassay-guided isolation and identification of  limonoids from S. macrophylla King 
 
RESULTS AND DISCUSSION 
 
Antifungal Screening of the Seed Fractions: 
The antifungal effect of the seed fractions has shown good levels of activity when screened against C. 
albicans, but some were found to have less effect on A. niger and A. flavus (Table 1). Assay showed that among 
fractionated extracts, ethyl acetate is more active than other fractions; the inhibition zones against all funguses 
ranging from 9.1 to 16.5 mm at a concentration of 10 mg/mL. Aqueous fraction showed good inhibition but 
slightly less than ethyl acetate against C. albicans (16.2 mm), A. niger (13.1 mm) and A. flavus (9.0 mm). Both 
hexane and chloroform fractions showed moderate to weak inhibitions against C. albicans (13.4 and 13.9 mm), 
against A. niger (12.4 and 12.1 mm) and against A. flavus (8.9 and 8.5 mm), respectively, at the same 
concentration. 
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Table 1: Antifungal activity of S. macrophylla seed fractions 
Inhibition zone (mm) a 
 Bacterial specie 
Fractions Con.mg/mL A. niger C. albicans A. flavus 
Hexane 10 12.4 ± 0.4a 13.4 ± 0.4a 8.9 ± 0.5a 
 5 11.3 ± 0.3 12.1 ± 0.3 8.2 ± 0.3 
Chloroform 10 12.1 ± 0.3a 13.9 ± 0.2a 8.7 ± 0.4a 
 5 12.3 ± 0.2 11.6 ± 0.5 8.5 ± 0.3 
Ethyl acetate 10 13.3 ± 0.5a 16.5 ± 0.1b 9.1 ± 0.2a 
 5 10.3 ± 0.2 13.8 ± 0.3 8.3 ± 0.4 
Aqueous 10 13.1 ± 0.2a 16.2 ± 0.4b 9.0 ± 0.2a 
 5 12.4 ± 0.4 15.8 ± 0.2 8.6 ± 0.1 
Fluconazole 10 µg/mL 23.6 ± 0.2 26.1 ± 0.1 21.0 ± 0.3 
DMSO 5% – – – 
aInhibition zone diameter including the diameter of the paper disc (6 mm); –: no growth inhibition; values were means of three replicates (± 
standard error mean); means with the different letter in the same column are significantly different at (p ˂ 0.05). 
 
Isolation of Compounds: 
Bioassay-guided fractionation using prep-HPLC of the ethyl acetate fraction led to isolation of four 
compounds, which were identified as limonoids. These compounds have been previously isolated from S. 
mahogany seed by column chromatography technique (Schefer et al., 2006; Philip et al., 2005). In this study, 
when the sample injected, four compounds were separated (Figure 2) and gave compounds 1 (14.4 mg at 2.15 
min); compound 2 (12.0 mg at 3.69 min); compound 3 (10.16 mg at 4.51 min) and compound 4 (10.18 mg at 
7.81 min). The pooled compounds were re-analysed by analytical HPLC to check the purity prior identification 
as indicated in Figure 3. 
 
Time
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00
A
U
0.0
2.0e-2
4.0e-2
6.0e-2
8.0e-2
1.0e-1
1.2e-1
1.4e-1
1.6e-1
1.8e-1
2.0e-1
analytical_03 Diode Array 
Range: 2.303e-12.15
4.51
3.69
7.81
 
Fig. 2: Chromatographic separation of the ethyl acetate fraction of S. macrophylla seed. 
 
The chromatogram obtained using preparative column C-18 at 230 nm 
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Fig. 3: Chromatographic separations of compounds 1-4, using analytical column. 
 
Structure Elucidation: 
Compound 1 was isolated as white crystals. The molecular formula was determined to be C27H34O8 with 11 
degrees of unsaturation in the molecule by positive FABMS (m/z 487 [M + H]+); mp: 175-178 ºC; and NMR 
data (Tables 2 and 3). The IR spectra showed the absorptions for OH group (3473 cm-1), carbonyl group (1718 
cm-1) and furan ring (880 cm-1). The 13C-NMR spectra (CD3OD, 125 MHz) displayed 27 carbon signals due to 
three carbonyls (ketone, ester and lactone), six sp3 methines, five methyl, four sp3 methylenes, three sp2 
methines, three sp3 quaternary carbons and three sp2 quaternary carbons. Among them, three sp3 methines δC 
77.88 (C-3), 72.90 (C-6) and 80.50 (C-17), two sp2 methines (δC 142.82 (C-23) and 109.63 (C-22) and one 
methyl 53.41 were ascribed to those bearing an oxygen atom. Comparison with information from literature 
(Schefer et al., 2006) suggests the swietenolide limonoid for compound 1 (Figure 4). 
Compound 2 was isolated as amorphous. The molecular formula was determined to be C27H34O7 with 11 
degrees of unsaturation in the molecule by positive FABMS (m/z 471 [M + H]+); mp: 186-189 °C; and NMR 
data (Tables 2 and 3). The IR spectra showed the absorptions for OH group (3413 cm-1), carbonyl group (1745 
cm-1) and furan ring (871 cm-1). The 13C-NMR spectra (CD3OD, 125 MHz) confirmed that compound 2 has 27 
carbon signals due to three carbonyls (one ketone, one ester and one lactone), five sp3 methines rather than six in 
comparison with compound 1, five sp3 methlenes, three sp2 quaternary carbons, three sp3 quaternary carbons, 
three sp2 methines and five methyls. Among them, two sp3 methines at δC 142.82 (C-23) and 141.35 (C-21), one 
sp3 methyl 54.14 and two sp3 methines 80.49 (C-17) and 77.88 (C-3) were ascribed to those bearing an oxygen 
atom. By comparing the spectral data with those reported in the literature (Philip et al., 2005) compound 2 was 
determined to be the proceranolide (Figure 4).  
Compound 3 was isolated as colourless needles crystal. The molecular formula was determined to be 
C34H42O10 with 14 degrees of unsaturation in the molecule by positive FABMS (m/z 611 [M + H]+); mp: 154-
156 °C ; and NMR data (Tables 2 and 3). The IR spectra showed the absorptions for OH group (3401 cm-1), 
carbonyl group (1641 cm-1) and furan ring (877 cm-1). The 13C-NMR spectra confirmed that compound 3 has 34 
carbon resonances due to five carbonyls rather than three or four in comparison with previous compounds (one 
ketone, three ester and lactone), six sp3 methines, eight methyls, four sp3 methylenes, three sp2 methines, three 
sp3 quaternary carbons and five sp2 quaternary carbons. Among them, three sp3 methines δC 77.44 (C-3), 72.64 
(C-6) and 78.33 (C-17), two sp2 methines (δC 143.23 (C-23) and 109.21 (C-22) and one methyl 50.01, were 
ascribed to those bearing an oxygen atom. It was consistent with the skeleton of 3-O-tigloyl-6-O-
acetylswietenolide (Jih-Jung et al., 2010). Therefore, compound 3 was determined to be 3-O-tigloyl-6-O-
acetylswietenolide (Figure 4).  
Compound 4 was isolated as colourless needles. The molecular formula was determined to be C34H42O10 
with 14 degrees of unsaturation in the molecule by positive FABMS (m/z 611 [M + H]+); mp: 130-133 °C; and 
NMR data (Tables 2 and 3). The IR spectra showed the absorptions for OH group (3461 cm-1), carbonyl group 
(1639 cm-1) and furan ring (875 cm-1). The NMR spectra confirmed that compound 4 is sharing similar NMR 
data as found for compound 3 indicating that the two structures are closely related, differing in only one aspect. 
While compound 3 has a double bond between C8-C14 carbons, compound 4 has a double bond between C8-
C30 carbons. A relevant and interesting point is the presence of a signal at δH 5.32 ppm, instead of a signal at δH 
2.26 ppm characteristic of the hydrogen H-30 when there is a double bond between C8-C30 carbons, which was 
noted in the 1H-NMR spectrum. Another prove lies in the presence of a signal at δC 122.15 instead of a signal at 
δC 36.53 characteristic of the carbon (C-30) when there is a double bond between C8-C30 carbons, which was 
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noted in the 13C-NMR spectrum. By comparing the spectral data with those reported in the literature (Dewanjee 
et al., 2009) compound 4 was determined to be the swietenine acetate (Figure 4). 
 
Table 2: 1H NMR data for compounds 1-4 (at 500 MHz in CD3OD,   in ppm, J in Hz). 
Position (H) 1 2 3 4 
2 2.95 (1H, m) 2.95 (1H, m) 3.47 (1H, m) 3.48 (1H, m) 
3 3.31 (1H, d, J = 0.5) 3.31 (1H, d, J = 0.5) 4.89 (1H, d, J = 0.5) 4.65 (1H, d, J = 0.5) 
5 3.37 (1H, s) 3.51(1H,dd,J=7.5,1.5) 4.67 (1H, s) 3.37 (1H, s) 
6 4.57 (1H, s) 2.59 (2H, m) 5.65 (1H, s) 5.65 (1H, s) 
9 1.89 (1H, m) 2.05 (1H, m) 1.78 (1H, m) 2.23 (1H, m) 
11 
 
1.13 (2H, m) 
1.75 (2H, m) 
1.81 (2H, m) 
1.88 (2H, m) 
2.30 (2H, m)  
1.95 (2H, m) 
1.88 (2H, m) 
1.99 (2H, m) 
12 
 
1.96 (2H, m) 
1.76 (2H, m) 
1.12 (2H, m) 
1.69 (2H, m) 
1.55 (2H, m) 
1.72 (2H, m) 
1.85 (2H, m) 
1.16 (2H, m 
14 ̶ ̶ ̶ 2.40 (1H, m) 
15 3.26 (2H, d, J = 2.5) 3.31 (2H, d, J = 2.5) 2.99 (2H, d, J = 2.5) 2.26 (2H, d, J = 2.5) 
17 5.67 (1H, s) 5.67 (1H, s) 5.63 (1H, s) 5.63 (1H, s) 
18 0.97 (3H, s) 1.01 (3H, s) 1.05 (3H, s) 1.05 (3H, s) 
19 1.39 (3H, s) 1.37 (3H, s) 1.22 (3H, s) 1.22 (3H, s) 
21 7.61 (1H, t, J = 0.5) 7.61 (1H, t, J = 0.5) 7.80 (1H, t, J = 0.5) 7.80 (1H, t, J = 0.5) 
22 6.52 (1H, dd, J = 2, 0.5) 6.52(1H,dd,J=2,0.5) 6.56(1H,dd,J= 1.5, 05) 6.56(1H,dd,J= 1.5, 0.5) 
23 7.53 (1H, t, J = 2) 7.53 (1H, t, J = 2) 7.58 (1H, t, J = 1.5) 7.58 (1H, t, J = 1.5) 
28 1.01 (3H, s) 0.92 (3H, s) 1.15 (3H, s) 1.15 (3H, s) 
29 0.92 (1H, s) 0.97 (3H, s) 1.01 (3H, s) 1.01 (3H, s) 
30 2.04 (2H, m) 3.14 (2H, m) 2.38 (2H, m) 5.31 (1H, d, J = 7.5) 
OCH3 3.97 (3H, s) 3.79 (3H, s) 3.77 (3H, s) 3.77 (3H, s) 
32 ̶ ̶ 2.21 (1H, s) 2.21 (3H, s) 
35 ̶ ̶ 6.94 (1H, qq, J = 7, 1.5) 6.94 (1H, qq, J = 7, 1.5) 
36 ̶ ̶ 1.73 (3H, d, J = 1) 1.73 (3H, d, J = 1) 
37 ̶ ̶ 1.71 (3H, d, J = 1) 1.72 (3H, d, J = 1 
 
 
Fig. 4: Structures of compounds 1-4. 
 
Table 3: 13C NMR data for compounds 1-4 (at 125 MHz in CD3OD, Ϩ  in ppm) 
Position (C) 1 2 3 4 
1 217.2 (C)      215.8 (C) 216.26 (C) 216.65 (C) 
2 50.99 (CH)      51.58 (CH) 48.86 (CH) 48.87 (CH) 
3 77.88 (CH)   77.88 (CH) 77.44 (CH) 78.33 (CH) 
4 44.02 (C)  50.99 (C) 44.44 (C) 38.72 (C) 
5 39.50 (CH)  44.01 (CH) 44.59 (CH) 44.45 (CH) 
6 72.90 (CH)     37.98 (CH2) 72.64 (CH) 72.64 (CH) 
7 176.57 (C)     176.58 (C) 171.48 (C) 171.48 (C) 
8 129.03 (C)   129.02 (C) 122.15 (C) 139.03 (C) 
9 51.59 (CH)  53.40 (CH) 52.39 (CH) 57.32 (CH) 
10 54.14 (C)      72.88 (C) 57.32 (C) 50.01 (C) 
11 28.94 (CH2)     18.39 (CH2) 20.31 (CH2) 19.45 (CH2) 
12 17.00 (CH2)   28.93 (CH2) 29.02 (CH2) 33.96 (CH2) 
13 37.70 (C)    39.58 (C) 38.72 (C) 36.54 (C) 
14 130.35 (C)    130.35 (C) 139.30 (C) 44.59 (CH) 
15 32.63 (CH2)    33.83 (CH2) 33.96 (CH2) 29.01 (CH2) 
16 172.69 (C)    172.70 (C) 169.92 (C) 169.92 
17 80.50 (CH) 80.49 (CH) 78.33 (CH) 77.24 (CH) 
18 18.40 (CH3)     16.99 (CH3) 21.71 (CH3) 20.30 (CH3) 
19 16.90 (CH3)    16.88 (CH3) 14.77 (CH3) 14.77 (CH3) 
20 120.99 (C) 120.98 (C) 121.06 (C) 121.05 (C) 
21 141.35 (CH) 141.35 (CH) 141.18 (CH) 141.18 (CH) 
22 109.63 (CH) 109.63 (CH) 109.21 (CH) 109.21 (CH) 
23 142.82 (CH) 142.82 (CH) 143.23 (CH) 143.23 (CH) 
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28 22.61 (CH3)    22.20 (CH3) 21.71 (CH3) 21.71 (CH3) 
29 23.07 (CH3)      22.60 (CH3) 22.09 (CH3) 22.09 (CH3) 
30 33.83 (CH2) 32.62 (CH2) 36.53 (CH2) 122.15 (CH) 
COOCH3 53.41 (CH3) 54.14 (CH3) 50.01 (CH3) 52.39 (CH3) 
31 − − 170.28 (C) 170.28 (C)   
32 − − 20.96 (CH3)  20.97 (CH3)     
33 − − 166.88 (C) 166.88 (C)    
34 − − 127.38 (C)   127.38 (C)    
35 − − 139.47 (CH) 139.47 (CH) 
36 − − 10.93 (CH3) 10.63 (CH3) 
37 − − 13.36 (CH3) 13.37 (CH3) 
 
Antifungal Activity of the Isolated Compounds (1-4): 
Antifungal activity of the four isolated compounds prepared in two different concentrations (50 and 100 
µg/mL) was tested against three fungal strains which were studied. Of the four compounds evaluated, 
compounds 1, 2 and 3 showed inhibition zones in all the fungal strains tested. Whereas, all tested funguses 
completely resistance to compound 4 and not observed any inhibition zones (Table 4). The highly strong 
antifungal activity was observed in compound 1 at a concentration 10 µg/mL against C. albacans (13.1 m), A. 
niger (10.2 m) and A. flavus (9.1 m). In the same above concentration, compounds 2 and 3 showed similar 
activity to each other, both inhibited the growth of the fungal A. flavus, C. albacans and A. niger with the 
inhibition zones of 4.2-4.3, 5.1-5.4 and 4.0-4.4 mm, respectively. It can explain that C. albacans is most 
sensitive of the tested funguses to these isolated compounds. 
 
Table 4: Inhibition zones (mm) of the isolated compounds 1-4 
Compounds Conc. µg/mL 
Inhibition zone (mm)a 
A. favus C. albacans A. niger 
Compound (1) 50 8.6 ± 0.3 12.1 ± 0.2 9.0 ± 0.1 
 100 9.1 ± 0.4 13.1 ± 0.1 10.2 ± 0.1 
Compound (2) 50 4.0 ± 0.1 5.1± 0.1 3.9 ± 0.4 
 100 4.3 ± 0.2 5.4 ± 0.1 4.4 ± 0.3 
Compound (3) 50 3.9 ± 0.1 4.8 ± 0.3 3.7 ± 0.2 
 100 4.2 ± 0.2 5.1 ± 0.3 4.0 ± 0.2 
Compound (4) 50 – – – 
 100 – – – 
Fluconazole 10 21.0 ± 0.3 26.1 ± 0.1 23.6 ± 0.2 
a Inhibition zone diameter including the diameter of the paper disc (6 mm); –: no growth inhibition; values were means of three replicates (± 
standard error mean) 
 
Compounds (1-3) had at least one free hydroxyl group as a common structural feature in carbon 3 or 6 
positions. Other than the presence of the free hydroxyl group, the individual compounds differed in the double 
bond position. Compound 4 has a characteristic 8,30-double bond, while compounds 1, 2 and 3 have an 8,14-
double bond. The result indicated that the double bond-position does not influence to the antifungal activity but 
suggested that hydroxyl group substitutions may be critical for the antifungal activity. No results concerning 
antifungal activity have been found in the literature for the isolated compounds. However, Maiti et al. (2007) 
reported the antifungal activity of S. macrophylla seed extract against Candida sp (C. albicans and C. albidus.) 
and Aspergillus sp (A. flavus and A. niger). Assay showed that the seed extract was more active against Candida 
sp. C. albicans strain in particular, used in this study is common causes of infections in long-term care units in 
hospitals. It is the leading cause of gastrointestinal tract, candidosis and otomycosis infections (Bulpa et al., 
2007; Eggimann et al., 2003). The significant antifungal activity caused by compound 1 against C. albicans, 
suggesting that this compound could play an active role in the protection against fungi related to several 
diseases. 
 
Conclusion: 
In conclusion, among four compounds which isolated from S. macrophylla seed, compound 1 
(swieteniolide) showed moderate antifungal activity against tested organisms. Its effect on tested organisms had 
the following order: C. albacans > A. niger > A. flavus. Compound 2 (proceranolide) and compound 3 (3-O-
tigloyl-6-O-acetylswietenolide), both are showed weak and similar activity. Whereas, all tested organisms 
completely resistance to compound 4 (swietenine acetate) and not observed any inhibition zones. 
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